BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2762 related articles for article (PubMed ID: 26928656)

  • 1. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.
    Ma Y; Dong S; Li X; Kim BYS; Yang Z; Jiang W
    Front Oncol; 2020; 10():606906. PubMed ID: 33628730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
    Moloudizargari M; Asghari MH; Goel A
    Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
    Lamichhane TN; Jay SM
    Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.
    Lamichhane TN; Raiker RS; Jay SM
    Mol Pharm; 2015 Oct; 12(10):3650-7. PubMed ID: 26376343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
    Wang L; Wang D; Ye Z; Xu J
    Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 139.